Curriculum Vitae

Rimal B. Bera, MD Clinical Professor of Psychiatry

Department of Psychiatry & Human Behavior University of California, Irvine

UCI Medical Center 101 City Drive South Orange, CA 92868 Office: (714) 456-6898 Fax: (714) 456-7519 Email: rbera@uci.edu EXPERIENCE: 1991 - Present Clinical Professor of Psychiatry Full-Time Faculty University of California Irvine Medical Center, Orange, CA. 1999 - Present Medical Director

Universal Care Behavioral Health, Garden Grove, CA 2012-Present Medical Director

John Henry Foundation Mental Health Center Santa Ana, CA

2011- 2015 Medical Director Pat Moore Foundation Alcohol and Drug Recovery Center,

Costa Mesa, CA 2004 - 2012 Chief Consulting Psychiatrist

Metropolitan State Hospital, Norwalk, CA 1993 - 2004 Medical Director, UCI Neuropsychiatric Hospital

University of California Irvine Medical Center, Orange, CA. 1992 - 1999 Medical Director - Partial Hospitalization Program UCI Neuropsychiatric Hospital, Orange, CA. 1988 - 1993 Staff Psychiatrist at Nancy’s Guest Village Board and Care Chronic and Acute Psychiatry, Garden Grove, CA. 1988 - 1992 Private Practice with Lakeview Medical Group, Inc. Geriatric Psychiatry, Orange, CA. 1989 Staff Psychiatrist - Southeast Council of Alcoholism and Drug

Problems, Inc. Chemical Dependency, Downey, CA. EDUCATION: 1987 - 1991 Psychiatry Residency Training Program University of California Irvine Medical Center

Rimal B. Bera, MD Page 2 California College of Medicine Orange, California 1983 - 1987 Doctor of Medicine University of California, Irvine School of Medicine Irvine, California 1979 - 1983 Bachelor of Science in Biological Sciences University of California, Irvine. Irvine, California HONORS: 2016 Physician of Excellence Award-Orange County Medical

Association 2014 Orange County Medical Association Physician of the Year 2014 Physician of Excellence Award-Orange County Medical

Association 2011 University of California Irvine Department of Psychiatry Teacher

of the Year. Awarded by Psychiatry Residency Class. 2009 Physician of Excellence Award-Orange County Medical

Association 2006 Orange County Mental Health Association Community Service Award Nominee 2005 Physician of Excellence Award-Orange County Medical

Association 2004 Orange County Mental Health Association Community Service Award Nominee 2003 Distinguished Fellow-American Psychiatric Association 2000 National Marrow Donor Program Volunteer Recognition Award- Organized Most Successful East Indian Bone Drive in North America. 2000 Elected Fellow-American Psychiatric Association 2000 American Psychiatric Association Public Affairs Network

Award for Media Relations 1999 Spirit of Philanthropy Honoree-Honored by the Orange County Chapter of the National Society of Fund Raising Executives 1999 Orange County Mental Health Association Community Service Award 1998 Lilly Schizophrenia Reintegration Award-Nominated by Orange County Psychiatric Society 1994 Janssen Clinical Scholar 1991 Physician Recognition Award - UCI Medical Center 1987 Sandoz Pharmaceutical Company Award - Outstanding Medical

Student in Psychiatry 1979 - 1987 University of California Regents Scholar GRANTS AND RESEARCH AWARDS:

Rimal B. Bera, MD Page 3

I have been a Co-Investigator on 114 grant-funded studies since July, 1991. From 2008 to 2014, I was a Primary Investigator on 5 Pharmaceutical industry grant-funded studies which range in amount from $131,000 to $499, 945. I have served on the Advisory Boards of Novartis, Lilly, Janssen, Pfizer, Merck, Bristol-Myers Squib. Otsuka, Alkermes and Astra-Zeneca Pharmaceuticals.

PROFESSIONAL ORGANIZATIONS AND OFFICES:

President--Board of Directors, UCI School of Medicine Alumni Association- 2012-2016 Psychiatry Chairman Search Committee, UCI School of Medicine-2013 - 2016 Board of Directors, UCI School of Medicine Alumni Association- 2007-present Program Director-UCI School of Medicine High School Medical School Forum- 2010 to present. UCI Residents Well Being Committee 2013-2016 Chairmen Strategic Planning Committee University of Southern California Parents Association 2012 to 2014 Board of Directors, Immediate Past President - Mental Health Association of Orange County. President 1997-1999. Vice President 1995-1997. Board Member 1992-2015. Orange County Psychiatric Society/Public Affairs Committee Chairman Executive Committee-Orange County Health Needs Assessment Hospital Credentials Committee, UCI Medical Center

Medicare Compliance Committee, UCI Medical Center Chairman of Quality Assurance/Utilization Review Committee,

UCI Department of Psychiatry UCI School of Medicine Medical School Admissions Interviewer 1993-Present Academic Society Leader, UCI School of Medicine, 2013-Present LCME Task Force Member, UCI School of Medicine 2015-2016

Chairman, Performance Task Force, UCI Department of Psychiatry Human Subjects Review Committee, UCI College of Medicine

California Psychiatric Association American Psychiatric Association Orange County Medical Association

LICENSURE AND EXAMINATIONS:

Board Certified, American Board of Psychiatry and Neurology Certificate No. 037133 California State Medical License No. G064160

Rimal B. Bera, MD Page 4 D.E.A. Registration No. BB1628758 PUBLICATIONS:

1. Bera, R., Costa, J., Sramek, J.: Control of Bed-Wetting with Benztropine. American Journal of Psychiatry 147:S, May 1990, pp674.

2. Bera, R., Sramek, J., Roy, S., Costa, J., Gulasekaram, B.: Relationship between Dose, Duration of Illness and Blood Levels of Fluphenazine and other Antipsychotics in Psychiatric Patients. In Keyzer (Executive Editor): Thiazines and Structurally Related Compounds. Malabar, Florida, Krieger Publishing Company, 1992, pp359-364.

3. Tewari, S., Diano, M., Bera, R.: Alteration in Brain Polyribosomal RNA Translation and Lymphocyte Proliferation in Prenatally Ethanol-Exposed Rats. Alcoholism: Clinical and Experimental Research. 1992; 16(3): pp436-442.

4. Bera, R., Roy, S., Costa, J.: Relationship Between Duration of Illness and Plasma Concentrations of Antipsychotics in Psychotic Patients. The Annals of Pharmacotherapy, 1992; 26: pp714-715.

5. Potkin, S.G., Bera, R., Gulasekaram, B., Costa, J., Hayes, S., Jin, Y., Richmond, G., Carreon, D., Sitanggan, K., Gerber, B., Telford, J., Plon, L., Plon, H., Park, L., Chang, Y., Cooper, T.: Plasma Clozapine Concentrations Predict Clinical Response in Treatment-Resistant Schizophrenia. Journal of Clinical Psychiatry, 1994:55(9, supplB): pp133-136.

6. Bera, R.: Invited to prepare a “Special Report” for the Directions in Psychiatry CME program on: How To Predict Clinical Response to Clozapine by Measuring Plasma Levels. Submitted October 15, 1996.

7. Potkin, S.G., Wu, J., Bera, R., Keator, D., Carreon, D., Aurang, C., Fallon, J., Zborowski, J., Sebree, T.: Is Sertindole an Atypical Neuroleptic?: PET Study of Changes in Regional Glucose Metabolism in Patients with Schizophrenia. Submitted to Archives of General Psychiatry, January 1997.

8. Risperidone-54 Study Results. Submitted to Psychopharmacology.

9. Potkin, S.G., Bera, R.: The Safety and Pharmacokinetics of Quetiapine When Coadminstered With Haloperidol, Risperidone, or Thioridazine. Journal of Clinical Psychopharmacology, 2002:22: pp121-130.

10. Bera, R.B., Offord, S., Zubek, D., Lau, G., Lin, J., Baker, R., Karson, C.: Impact on healthcare resource usage and costs among Medicaid-insured schizophrenia patients after initiaition

Rimal B. Bera, MD Page 5

of treatment with long-acting injectable antipsychotics. Journal of Medical Economics, 2013:16; pp 522-528.

11. Bera, R.B., Potkin, S., Zubek, D., Lau, G.: Perspectives on Long-Acting Injectable Antipsychotics for Schizophrenia: Consideration of Patient Cultural/Racial Differences in Planning Individual Treatment. Submitted to Journal of Clinical Psychiatry in June 2013.

ABSTRACTS:

1. Bera, R., Potkin, S.: Relationship between Neuroleptic Dose and Blood Level in Chronic Psychiatric Patients. American Psychiatric Association Annual Meeting, May12-17, 1990, New York, NY

2. Bera, R., Sramek, J., Roy, S., Costa, J., Gulasekaram, B.: Relationship between Dose, Duration of Illness and Blood Levels of Fluphenazine and other Antipsychotics in Psychiatric Patients. The Sixth International Conference on Phenothiazines and Structurally Related Psychotropic Compounds, Sept 11-14, 1990, Pasadena, Ca.

3. Jin, Y., Potkin, S., Bera, R., Wu, J., Costa, J., Lee, A., Gulasekaram, B., Sandman, C.: Topographical Alpha EEG Spectrum Differences Following Photic Driving in Normal Subjects and Schizophrenic Patients. Poster Presentation, Society of Biological Psychiatry Annual Meeting, April 29 - May 3, 1992, Washington DC Abstract published in Supplement to Biological Psychiatry, 31 (5A), 1992.

4. Potkin, S., Jin, Y., Bera, R., Wu, J., Sandman, C., Bunney, W.E. Jr.: EEG Photic Driving in Chronic PCP Users, Schizophrenic Patients, and Normal Controls. Poster Presentation, Society of Biological Psychiatry Annual Meeting, April 29 - May 3, 1992, Washington DC Abstract published in Supplement to Biological Psychiatry, 31 (5A), 1992.

5. Potkin, S., Bera, R., et. al.: High and Low Dose Clozapine Compared in a Double-Blind Study. International Congress on Schizophrenia Research, April 17-21, 1993, Colorado Springs, Co.

6. Jin, Y., Wu, J., Bera, R., Potkin, S.: Negative Symptoms of Schizophrenia Associated with EEG Activity. International Congress on Schizophrenia Research, April 17-21, 1993, Colorado Springs, Co.

7. Jin, Y., Wu, J., Sandman, C., Bera, R., Richmond, G., Potkin, S.: Negative Symptoms of Schizophrenia Related to Alpha & Beta EEG Activity. Society of Biological Psychiatry Meeting, May, 1993, San Francisco, Ca.

Rimal B. Bera, MD Page 6

8. Jin, Y., Bera, R., Chen, R., Wu, J., Sandman, C., Potkin, S.: Abnormal Photic Driving in Schizophrenia: An Improved FFT Methodology. Society of Biological Psychiatry Meeting, May 1993, San Francisco, Ca.

9. Potkin, S., Bera, R., Gulasekaram, B., Jin, Y., Costa, J., Gerber, B., Richmond, G., Ploszaj, D., Carreon, D., Cooper, T., Sitanggan, K.: Plasma Clozapine Concentrations Associated with Clinical Efficacy. Society of Biological Psychiatry Meeting, May 1993, San Francisco, Ca.

10. Potkin, S., Zborowski, J., Wu, J., Mack, R., Bera, R., Sebree, T., Aurang, C., Bunney, W.: Brain Imaging to Determine the Effects of Sertindole in Schizophrenic Patients. Society of Biological Psychiatry Meeting, May 1-5 1996, New York, NY.

11. Bera, R., Kalali, A.H., Potkin, S.: Predicting Clinical Response to Clozapine Treatment by Plasma Level. Society of Biological Psychiatry Meeting, May 1-5 1996, New York, NY.

12. Bera, R., Kalali, A.H., Potkin, S.: The Relationship Between Clozapine Dose, Plasma Level and Side Effects. Society of Biological Psychiatry Meeting, May 1-5 1996, New York, NY.

13. Potkin, S., Zborowski, J., Wu, J., Mack, R., Aurang, C., Sebree, T., Carreon D., Bera, R.: Brain Imaging to Determine the Effects of Sertindole in Schizophrenic Patients. 36th Annual Meeting of the New Clinical Drug Evaluation Unit Program, May 28-31, 1996, Boca Raton, Fl.

14. Fleming, K., Moenter, J., Bera, R., Carreon, D., Potkin, S.: Differential Retention of Emotional Material in Patients with Schizophrenia. American Psychiatric Association Annual Meeting, May 4-9, 1996, New York, NY.

15. Bera, R., Potkin, S.: Brain Imaging to Determine the Effects of Sertindole in Schizophrenic Patients. Schizophrenia 1996: Breaking Down the Barriers, 4th International Conference, October 6-9, 1996, Vancouver, BC, Canada.

16. Kalali, A.H., Bera, R., Potkin, S.: Health Care Reform and the Research Ward-A Critical Resource for Resident Education in Psychiatry. Schizophrenia 1996: Breaking Down the Barriers, 4th International Conference, October 6-9, 1996, Vancouver, BC, Canada.

17. Thyrum, P.T, Yeh, C., Potkin, S.G., MaGuire, G., Bera, R., Carreon, D., Arvanitis, LA: Safety and Tolerability of Switching From Conventional Antipsychotic Therapy to Seroquel (Quetiapine Fumarate) Followed by Abrupt Withdrawal From Seroquel. 1997 ACNP Annual Meeting, Kameula, Hawaii, December 7-12, 1997.

18. Potkin SG, Thyrum PT, Bera R, Vargo D, Carreon D, Kalali A, Maguire G, Yeh C, Ewing BJ, Wong J: Pharmacokinetics and

Rimal B. Bera, MD Page 7

Safety of Lithium Co-Administered with Seroquel(Quetiapine). International Congress on Schizophrenia Research, 1997.

19. Potkin SG, Bera R, Keator D, Fleming K, Alva G, Carreon D, Kranz L: Distinguishing Predominantly Negative Symptom Schizophrenia with FDG PET. International Congress on Schizophrenia Research, Santa Fe, New Mexico, April 17-21, 1999.

20. Karson, C., Bera, R: Cultural Factors in Decision making for Long Acting Injectables. American College of Neuropsychopharmacology. December 2012. Boca Rotan, Florida.

21. Bera, R.B.: Reduced Frequency of hospitalization and use of psychotropics in Schizophrenic patients following the introduction of long acting depot injections. Association of Managed Care Pharmacies. April 2013. San Diego, Ca.

22. Bera, R.B.: Reduced Frequency of hospitalization and use of psychotropics in Schizophrenic patients following the introduction of long acting depot injections. International Congress on Schizophrenia Research. April 2013. Orlando, Florida

23. Bera, R.B., Potkin, S., Zubek, D., Lau, G.: Patient and Prescriber Perspectives on Long-Acting Antipsychotics for Schizophrenia: Analysis of In-Office Discussion. American Psychiatric Association. May 2013. San Francisco, Ca.

24. Bera, R.B., Potkin, S., Zubek, D., Lau, G.: Perspectives on Long-Acting Antipsychotics for Schizophrenia: Consideration of Patient/Cultural Differences in Planning Individual Treatment. American Psychiatric Association. May 2013. San Francisco, Ca.

25. Bera, R.B., Potkin, S., Zubek, D., Lau, G.: An Analysis of Patient and Prescriber Perspectives on Long-Acting Antipsychotics for Schizophrenia Based on In-Office Discussion. New Clinical Drug Evaluation Unit (NCDEU) Annual Meeting. May 2013. Hollywood, Fl.

26. Bera, R.B. Parekh, N.: The Effect of Long Acting Injectibles on Polypharmacy. American Psychiatric Association Annual Meeting. May 2016. Atlanta, GA.

27. Bera, R.B., Parekh, N.: The Effect of Long Acting Injectibles on Caretaker Burden. American Psychiatric Association Annual Meeting. May 2016. Atlanta, GA.

28. Bera, K.R., Bera R.B.: Screening for Pseudobulbar Affect in an Outpatient Mental Health Clinic. American Psychiatric Association Annual Meeting. May 2017. San Diego, CA.

Rimal B. Bera, MD Page 8 PRESENTATIONS:

1. Orange County Psychiatric Society - Mental Illness Awareness Week Lecture. “Inpatient Psychiatry-Indications and Treatments.” October 8, 1991, Santa Ana, Ca.

2. Western Medical Center, Department of Psychiatry. “The Use of Clozapine in Psychiatry.” October 30, 1991, Anaheim, Ca.

3. Riverside County Department of Health Annual Meeting. “Schizophrenia and Family Dynamics.” March 27, 1992, Riverside, Ca.

4. Korean Psychiatric Association. “Update on the Use of Clozapine.” April 24, 1992, Los Angeles, Ca.

5. South Bay Alliance for the Mentally Ill. “Working with Families of the Chronically Mentally Ill.” July 20, 1992, Torrance, Ca.

6. Orange County Psychiatric Society - Mental Illness Awareness Week. “Recent Research Developments in the Treatment of Chronic Mental Illness.” October 6, 1996, Orange, Ca.

7. Sylmar Medical Center, Department of Psychiatry. “Long term Management of Patients with Schizophrenia.” February 23, 1993, Granada Hills, Ca.

8. Southern California Asian Indian Society. “Understanding our Youth in America.” March 7, 1993, Buena Park, Ca.

9. University of California, Irvine, Department of Psychiatry. “Clozaril Use - Management of Side Effects.” March 18, 1993, Orange, Ca.

10. Norwalk - La Mirada School District. “Career Day - Life as a Medical Doctor.” May 7, 1993, Norwalk, Ca.

11. San Diego County Psychiatrists. “Clozaril in Treatment Refractory Schizophrenia.” June 8, 1993, La Jolla, Ca.

12. Mental Health Association of Orange County. “Mental Illness Research and Treatment at UCI Medical Center.” June 17, 1993, Orange, Ca.

13. Metropolitan State Hospital Grand Rounds. “Clinical Update and Management of Clozaril.” June 23, 1993, Norwalk, Ca.

14. Orange County Jail Psychiatry Department. “Initiating the Use of Clozaril.” July 9, 1993, Santa Ana, Ca.

15. Harbor-UCLA Department of Psychiatry. “Update on Clozaril Use.” August 5, 1993, Torrance, Ca.

16. Northridge General Hospital, Department of Psychiatry. “Clinical Indications for Clozaril.” September 22, 1993, Northridge, Ca.

17. University of California, Irvine Medical Center - Mental Illness Awareness Week. “New Treatments in Schizophrenia.” October 7, 1993, Orange, Ca.

Rimal B. Bera, MD Page 9

18. Southern California Asian-Indian Conference. “Understanding Your Youth in America.” October 10, 1993, Buena Park, Ca.

19. California Correctional Institute for Women. “Initiating the Use of Clozaril.” November 17, 1993, Chino, Ca.

20. Starting Point of Orange County Hospital. “New Treatments in Schizophrenia.” November 30, 1993, Costa Mesa, Ca.

21. Orange County Mental Health Clinic. “Using Clozaril in the Outpatient Setting.” January 20, 1994, Anaheim, Ca.

22. Schizophrenia National teleconference Series: Sponsored by Sandoz Pharmaceutical Corporation. “New Approaches to Treating the Chronically Mentally Ill.” Gave 20 national teleconferences from February, 1994 to September, 1994 on the topic.

23. Orange County Mental Health Clinic. “Using Clozaril in the Outpatient Setting.” March 14, 1994, Westminster, Ca.

24. South Coast Alliance for the Mentally Ill. “New Treatment Strategies for the Mentally Ill.” April 9, 1994, Laguna Hills, Ca.

25. Orange County Mental Health Clinic. “Using Clozaril in the Outpatient Setting.” May 1, 1994, Fullerton, Ca.

26. Orange County Mental Health Clinic. “Using Clozaril in the Outpatient Setting.” May 20, 1994, Aliso Viejo, Ca.

27. San Francisco Alliance for the Mentally Ill. “New Approaches to Treating of the Chronically Mentally Ill.” June 4, 1994, San Francisco, Ca.

28. Board and Care Directors of Los Angeles County. “Clozaril and the Management of the Schizophrenic Patients.” June 23, 1994, Long Beach, Ca.

29. California State Association of Public Guardians, Public Administrators and Public Conservators Fall Conference. “A Biopsychosocial Approach to the Treatment of Schizophrenia.” September 20, 1994, Riverside, Ca.

30. University of California, Irvine Medical Center - Mental Illness Awareness Week. “Schizophrenia: New Developments and Treatments.” October 4, 1994, Orange, Ca.

31. Starting Point Partial Hospital Program. “How to use DSM-IV.” November 13, 1994, Santa Ana, Ca.

32. Orange County Board and Care Administrators. “The Newest Treatments in Schizophrenia.” January 21, 1995, Orange, Ca.

33. University of Southern California, Department of Psychiatry. “How to Optimize Treatment with Clozaril.” May 10, 1995, Pasadena, Ca.

34. Los Angeles County Department of Mental Health. “New Antipsychotics.” August 1, 1995, Harbor-UCLA Medical Center, Torrance, Ca.

Rimal B. Bera, MD Page 10

35. University of California, Irvine Neuropsychiatric Center - Mental Illness Awareness Week. “New Treatments in Schizophrenia.” October 4, 1995, Orange, Ca.

36. South Coast Medical Center Partial Hospital Program. “How to Optimize the Treatment of the Chronically Mentally Ill.” December 14, 1995, Santa, Ana, Ca.

37. Alliance of the Mentally Ill of Long Beach. “New Treatments and Research for Schizophrenia.” February 7, 1996, Long Beach, Ca.

38. Superior Court of the State of California, County of Orange. “How to Perform Psychiatric Evaluations.” March 28, 1996, Orange, Ca.

39. Metropolitan State Hospital. “Update on Clozaril.” May 20, 1996, Norwalk, Ca.

40. Metropolitan State Hospital. “Standard of Care in Schizophrenia.” September 25, 1996, Norwalk, Ca.

41. California Department of Mental Health. “Introduction to the Use of Olanzapine.” October 22, 1996, Los Angeles, Ca.

42. County of Orange, Department of Mental Health. “The Use of Olanzapine in Schizophrenia.” October 23, 1996, Santa Ana, Ca.

43. University of California, Irvine, Department of Psychiatry Grand Rounds. “Treatment Options for Schizophrenia.” November 19, 1996, Orange, Ca.

44. California Institute for Mental Health. “Introduction to the Use of Olanzapine.” December 4, 1996, Sacramento, Ca.

45. Long Beach Veteran’s Administration Department of Psychiatry Grand Rounds. “Newest Treatments for Schizophrenia.” January 29, 1997, Long Beach, Ca.

46. Western State Hospital Grand Rounds. “Update on the Use of Olanzapine.” February 20, 1997, Tacoma, WA.

47. Comprehensive Psychiatric Care Center. “The Use of the New Antipsychotics.” February 20, 1997, Tacoma, WA.

48. Private Practice Psychiatrists. “Update on the Use of Olanzapine.” February 20, 1997, Seattle WA.

49. Scripps Memorial Hospital Department of Psychiatry. “How to Utilize Olanzapine in your Practice.” March 4, 1997, San Diego, Ca.

50. San Diego County Mental Health Department. “The Newest Treatments for Schizophrenia.” March 20, 1997, San Diego, Ca.

51. Foundation Health Plan, FHP. “How Olanzapine Compares to the Other Antipsychotics.” March 27, 1997, Sacramento, Ca.

52. Orange County Community Psychiatrists. “Update on the Use of Olanzapine.” March 27, 1997, Santa Ana, Ca.

Rimal B. Bera, MD Page 11

53. Santa Clara County Department of Psychiatry. “The Use of the Novel Antipsychotics.” April 23, 1997, San Jose, Ca.

54. San Mateo County Private Practice Psychiatrists. “Introduction to the Use of Olanzapine.” April 24, 1997, San Mateo, Ca.

55. Napa State Hospital. “The Optimal Use of Olanzapine in the State Hospital Setting.” April 24, 1997, Yountville, Ca.

56. Kaiser Hospital Department of Psychiatry. “How to Use Olanzapine in Your Practice.” May 14, 1997, Woodland Hills, Ca.

57. Pacific Rim Psychopharmacology Annual Meeting. “The Predictive Value of Using Clozapine Blood Levels.” May 18, 1997, San Diego Ca.

58. Palm Springs Private Practice Psychiatrists. “Introduction to the Use of Olanzapine.” June 3, 1997, Rancho Mirage, Ca.

59. Riverside County Psychiatrists. “Optimal Use of the New Antipsychotics.” June 19, 1997, Riverside, Ca.

60. University of California, San Francisco, Department of Psychiatry Grand Rounds. “Devising the Ideal Plan of Care for Schizophrenia.” July 10, 1997, San Francisco, Ca.

61. Community Psychiatrists. “The Use of the Atypicals.” July 10, 1997, Burlingame, Ca.

62. University of California, San Francisco Psychopharmacology Seminar. “Complex Cases of Psychosis.” July 11, 1997.

63. Monterey County Department of Psychiatry. “Update on the Use of Olanzapine.” August 13, 1997, San Jose, Ca.

64. University of California, Irvine, Department of Psychiatry Grand Rounds. “Competency of Psychiatric Patients to Consent to Research.” August 26, 1997, Orange, Ca.

65. Riverside County General Hospital. “The Use of the Atypicals in the Inpatient Setting.” August 28, 1997, Riverside, Ca.

66. Orange County Private Psychiatrists. “Clinical Utilization of the New Atypical Antipsychotics.” September 24, 1997, Orange, Ca.

67. University of Southern California Department of Psychiatry Grand Rounds. “Introduction to the New Antipsychotics.” October 12, 1997, Rosemead, Ca.

68. Atascadero State Hospital Grand Rounds. “The use of PET Scan in Psychiatry.” October 22, 1997, Atascadero, Ca.

69. Southern California Psychiatric Society. “Clinical Utilization of the New Antipsychotics.” January 29, 1998, Riverside, Ca.

70. Southern Nevada Psychiatric Society. “Re-introduction of the Use of Clozapine.” February 5, 1998, Las Vegas, NV.

71. Mental Health Association of Orange County. “How to Optimize the Use of Antipsychotics.” February 9, 1998, Santa Ana, Ca.

Rimal B. Bera, MD Page 12

72. Alliance for the Mentally Ill of Orange County. “New Findings in the Treatment of Schizophrenia.” February 21, 1998, Orange, Ca.

73. Hawaii Psychiatric Society. Co-Chair with Dr. Gil Honingfeld for Clozaril Regional Advisory Board Presentation. March 28, 1998, Kapalua, Maui, Hawaii.

74. Norwalk-La Mirada School District Elementary Schools. “Career Day: Life as a Physician.” April 3, 1998, Norwalk, Ca.

75. Orange County Mental Health Department. “The Latest Findings in the Cause and Treatment of Schizophrenia.” April 8, 1998, Orange, Ca.

76. South Coast Medical Center Outpatient Psychiatry Department. “The Latest Advances in Treating the Difficult Psychotic Patient.” July 24, 1998, Santa Ana, Ca.

77. County of Orange Mental Health Case Managers Monthly Meeting. “Treatment of Psychotic Driven Agitation.” August 12, 1998, Orange, Ca.

78. University of California, Irvine Department of Psychiatry Grand Rounds. “Measuring Outcome in Schizophrenia: Differences Among the Atypical Antipsychotics.” October 13, 1998, Orange, Ca.

79. Alliance for the Mentally Ill of Orange County. “The Latest Treatments for Schizophrenia.” November 21, 1998, Orange, Ca.

80. Orange County Mental Health Department. “Brain Neurotransmitters.” January 13, 1999, Orange Ca.

81. League of Women’s Voters for Orange County. “What is Mental Illness?” January 16, 1999, Orange, Ca.

82. University of California, Irvine, Department of Psychiatry Grand Rounds. “Novel Treatments for Bipolar Affective Disorder.” January 19, 1999, Orange, Ca.

83. Orange County Department of Mental Health. “The Clinical Assessment of Movement Disorders in Psychiatric Patients.” February 5, 1999, Orange, Ca.

84. Southern Nevada Psychiatric Society. “Measuring Outcome in Schizophrenia: Differences Among the Atypical Antipsychotics.” March 10, 1999, Las Vegas, Nevada.

85. Metropolitan State Hospital Grand Rounds. “The Clinical Assessment of Movement Disorders in Psychiatric Patients.” March 11, 1999, Norwalk, Ca.

86. Riverside County Department of Mental Health. “How the Atypical Antipsychotics Compare to Each Other.” March 24, 1999, Riverside, Ca.

Rimal B. Bera, MD Page 13

87. University of California, Department of Psychiatry, Grand Rounds. “How to Evaluate Movement Disorders Using Rating Scales.” April 27, 1999, Orange, Ca.

88. Maricopa County Mental Health Department. “Differences Among the Atypical Antipsychotics.” May 11, 1999, Phoenix, AZ.

89. Maricopa County Medical Center Department of Psychiatry Grand Rounds. “The Clinical Assessment of Movement Disorders in Psychiatric Patients.” May 12, 1999, Phoenix, AZ.

90. Private Practice Psychiatrists in Maricopa County. “The Clinical Assessment of Movement Disorders in Psychiatric Patients.” May 12, 1999, Phoenix, AZ.

91. Fairview State Hospital, Grand Rounds. “The Use of Atypical Antipsychotics to Treat Aggression.” May 25, 1999, Costa Mesa, Ca.

92. Napa St. Hospital, Department of Psychiatry, Grand Rounds. “Measuring Outcomes in Schizophrenia: Differences Among the Atypical Antipsychotics.” June 7, 1999, Napa, Ca.

93. Napa County Mental Health Department. “How the Atypical Antipsychotics Differ From Each Other.” June 7, 1999, Yountville, Ca.

94. Palo Alto VA Department of Psychiatry Grand Rounds. “Differences Among the Atypical Antipsychotics.” June 8, 1999, Palo Alto, Ca.

95. Portland Oregon Psychiatric Society. “Differences Among the Atypical Antipsychotics.” July 13, 1999, Portland, Or.

96. Private Practice Psychiatrists in Boise, Idaho. “Use of the Atypical Antipsychotics in the Non-Schizophrenic Population.” July 14, 1999, Boise, Idaho.

97. Eastern State Psychiatric State Hospital Grand Rounds. “The Clinical Assessment of Movement Disorders in Psychiatric Patients.” July 15, 1999, Spokane, WA.

98. Private Practice Psychiatrists in Spokane, Washington. “Use of the Atypical Antipsychotics in the Non-Schizophrenic Population.” July 15, 1999, Spokane, WA.

99. University of Washington Department of Psychiatry Grand Rounds. “Differences Among the Atypical Antipsychotics.” July 16, 1999, Seattle, WA.

100. Private Practice Psychiatrists in Seattle, Washington. “Use of the Atypical Antipsychotics in the Non-Schizophrenic Population.” July 16, 1999, Seattle, WA.

101. Pharmaca Corp. Monthly Meeting. “Determining the Optimal Use of the Atypical Antipsychotics.” July 26, 1999, Van Nuys, Ca.

Rimal B. Bera, MD Page 14

102. Salt Lake City Veterans Administration Department of Psychiatry Grand Rounds. “Measuring Outcomes in Schizophrenia: Differences Among the Atypical Antipsychotics.” July 28, 1999, Salt Lake City, Utah.

103. Salt Lake City Private Practice Psychiatrists. “Differences Among the Atypical Antipsychotics.” July 28, 1999, Salt Lake City, Utah.

104. Utah State Hospital Grand Rounds. “Determining the Optimal Use of the Atypical Antipsychotics.” July 29, 1999, Provo, Utah.

105. Pharmamerica Pharmaceutical Corp. “Differences Among the Atypical Antipsychotics.” August 2, 1999, Cypress, Ca.

106. Private Practice Psychiatrists in Orange County. “Update on the Differences Among the Atypical Antipsychotics.” August 25, 1999, Laguna Beach, Ca.

107. Fresno County Medical Center Department of Psychiatry. “Maximizing Outcomes in Schizophrenia.” September 9, 1999, Fresno, Ca.

108. Hawaii State Psychiatric Hospital. “Differences Among the Atypical Antipsychotics.” October 13, 1999, Honolulu, Hawaii.

109. Private Practice Psychiatrists in Oahu, Hawaii. “The Use of the Atypical Antipsychotics in the Non-Schizophrenic Population.” October 13, 1999, Honolulu, Hawaii.

110. Pharmamerica Pharmacists. “How to Evaluate Outcomes with the Atypical Antipsychotics.” October 14, 1999, Honolulu, Hawaii.

111. Honolulu VA Department of Psychiatry. “Differences Among the Atypical Antipsychotics.” October 14, 1999.

112. Alameda County Department of Psychiatry. “Measuring Outcomes in Schizophrenia.” October 25, 1999, Oakland, Ca.

113. Harbor-UCLA Department of Psychiatry. “Update on the Differences Among the Atypical Antipsychotics.” November 2, 1999, Torrance, Ca.

114. Nevada State Psychiatric Hospital. “Update on the Differences Among the Atypical Antipsychotics.” November 17, 1999, Reno, NE.

115. Long Beach, California Private Practice Psychiatrists. “Measuring Outcomes in Schizophrenia.” December 1, 1999, Long Beach, Ca.

116. Western State Hospital Department of Psychiatry. “Update on the Differences Among the Atypical Antipsychotics.” December 2, 1999, Tacoma, WA.

117. Orange County Private Practice Psychiatrists. “Update on the Use of Depakote in Psychiatry.” December 11, 1999, Orange, Ca.

Rimal B. Bera, MD Page 15

118. Hennepin County Mental Health. “Differences Among the Atypical Antipsychotics.” January 6, 2000, Minneapolis, MN.

119. Hennepin County Private Practice Psychiatrists. “The Use of the Atypical Antipsychotics in the Non-Schizophrenic Population.” January 6, 2000, Minneapolis, MN.

120. St. Paul Hospital. “Treatment of Psychosis in the Geriatric Population.” January 7, 2000, St. Paul, MN.

121. Hennepin County Medical Center. “Measuring Outcomes in Schizophrenia.” January 7, 2000. Minneapolis, MN.

122. Southern California Psychiatric Society. “How the New Neuroleptics Compare to Each Other.” February 17, 2000. Torrance, Ca.

123. Good Samaritan Medical Center Department of Psychiatry. “Clinical Assessment of Movement Disorders in the Psychiatric Patient.” February 25, 2000. Phoenix, AZ.

124. Medford, Oregon Private Practice Psychiatrists. “Differences Among the Atypical Antipsychotics.” March 6, 2000. Medford, Oregon.

125. Roseburg VA Department of Psychiatry. “The Use of the Atypical Antipsychotics in the Non-Schizophrenic Population.” March 7, 2000. Roseburg, Oregon.

126. Eugene, Oregon Community Psychiatrists. “Update on the New Treatments for Schizophrenia.” March 7, 2000. Eugene, Oregon.

127. Salem, Oregon Private Practice Psychiatrists. “Maximizing the Potential of the Current Atypical Antipsychotics.” March 8, 2000. Salem, Oregon.

128. Portland, Oregon Community Psychiatrists. “A Roundtable Discussion of the New Antipsychotics.” March 8, 2000. Portland, Oregon.

129. Olive View Medical Center Department of Psychiatry. “Measuring Outcomes in Schizophrenia.” March 9, 2000. Sylmar, Ca.

130. South Bay Community Psychiatrists. “Optimizing our Current Treatments for Psychosis.” March 9, 2000. Torrance, Ca.

131. Mental Health Association of Montana. Keynote Speaker and Conference Presenter: “Psychotic Disorders” March 23, 2000. Billings, MT.

132. Department of Psychiatry, Long Beach VA. “Update on New Treatments for Psychosis.” March 27, 2000. Long Beach, Ca.

133. Department of Mental Health-Wisconsin. “Choosing the Appropriate Antipsychotic” April 11, 2000. Koehler, WI.

134. Private Practice Psychiatrists-Milwaukee. “Maximizing Outcomes in Schizophrenia” April 12, 2000. Milwaukee, WI.

Rimal B. Bera, MD Page 16

135. Sutter Community Hospital Department of Psychiatry. “Update on the Use of Seroquel” April 18, 2000. Sacramento, Ca.

136. Placer County Mental Health Department. “Differences Among the Atypical Antipsychotics” April 18, 2000. Folsom, Ca.

137. Kern County Department of Mental Health. “Maximizing Outcomes in Schizophrenia” April 25, 2000. Bakersfield, Ca.

138. Astra-Zeneca Pharmaceutical Representatives. Course Director for Introduction to Psychiatric Diagnosis and Treatment. May 22, 2000. Woodland Hills, Ca.

139. Vancouver State Hospital Department of Psychiatry. “Clinical Assessment of Movement Disorders in Psychiatric Patients” May 24, 2000. Vancouver, Canada.

140. Metropolitan Hospital Department of Psychiatry. “Update on the New Atypical Antipsychotics” May 24, 2000. Vancouver, Canada.

141. Vancouver County Mental Health Department. “The Use of the Atypical Antipsychotics in the Non-Schizophrenic Population” May 25, 2000. Vancouver, Canada.

142. Victoria General Hospital Department of Psychiatry. “Clinical Efficacy of the Atypicals” May 25, 2000. Victoria, Canada.

143. Sussex Community Psychiatrists. “How the Atypical Antipsychotics Compare to Each Other” May 25, 2000. Sussex, Canada.

144. St. Paul Hospital Department of Psychiatry. “Differences Among the Atypicals” May 26, 2000. Vancouver, Canada.

145. St. Joseph’s Hospital Department of Psychiatry. “The Use of Mood Stabilizer’s in Psychosis” January 9, 2000. Orange, Ca.

146. Contra Costa Medical Center. “Expanded Uses of the Atypical Antipsychotics” June 13, 2000. Martinez, Ca.

147. San Francisco Community Psychiatrists. “Measuring Outcomes Among the Atypical Antipsychotics” June 13, 2000. San Francisco, Ca.

148. Los Angeles County Private Practice Psychiatrists. “Comprehensive Update on How the Atypicals Compare” July 13, 2000. Hollywood, Ca.

149. Greater Southern California Private Practice Psychiatrists. “Mending the Mind: Painstaking Cures” July 14, 2000. Laguna Beach, California.

150. Tacoma Mental Health Department. “Update on the use of Seroquel in Psychosis” July 28, 2000. Tacoma, Washington.

151. Western State Psychiatric Hospital. “The Use of the Atypical Antipsychotics in the Non-Schizophrenic Population” July 29, 2000. Tacoma, Washington.

Rimal B. Bera, MD Page 17

152. Loma Linda VA Department of Psychiatry. “Rapid Use of the Atypical Antipsychotics on the Inpatient Setting” August 15, 2000. Loma Linda, California.

153. Tri City Mental Health Center Grand Rounds. “Maximizing the Use of the Atypicals” August 26, 2000. Pomona, Ca.

154. Los Angeles County Private Practice Psychiatrists. “Options in the Difficult to treat Psychotic Patient” September 10, 2000. San Pedro, California.

155. Houston Private Practice Psychiatrists. “Differences Among the Atypicals: An Updated Focus on Seroquel” October 5, 2000. Houston, Texas.

156. Maricopa County Medical Center Department of Psychiatry. “Optimizing Outcomes in Psychiatry: A Review of the Atypicals” October 13, 2000. Phoenix, Arizona.

157. Phoenix Private Practice Psychiatrists. “Differences Among the Atypicals” October 13, 2000. Phoenix, Arizona.

158. Kino Community Medical Center Department of Psychiatry. “Optimal Use of the New Antipsychotics in the Outpatient Setting” October 14, 2000. Tuscon, Arizona.

159. Tuscon Private Practice Psychiatrists. “Evaluating the Ideal Choice of Treatment” October 14, 2000. Tuscon, Arizona.

160. Orange County Mental Health Center-Santa Ana. “Special Issues in the Treatment of Psychosis in Women” October 29, 2000, Santa Ana, California.

161. South Bay Private Practice Psychiatrists. “Olanzapine in the Mood Disorder Population” November 13, 2000. Torrance, California.

162. Los Robles Community Medical Center. “Update on the Treatment and Diagnosis of Schizophrenia” December 1, 2000. Thousand Oaks, California.

163. San Luis Obispo County Psychiatrists. “New Ways to Treat Impulsive Aggression” December 9, 2000. Paso Robles, Ca.

164. Orange County Private Practice Psychiatrists. “New Treatments in Bipolar Affective Disorder” December 14, 2000. Anaheim, California.

165. Supelveda VA Department of Psychiatry. “Differences Among the Atypicals” January 17, 2001. Supelveda, Ca.

166. Napa State Hospital Department of Psychiatry. “Use of the Atypicals in the Treatment Refractory Population” February 1, 2001. Napa, Ca.

167. San Francisco City Private Practice Psychiatrists. “Maximizing Outcomes in Schizophrenia” February 1, 2001. San Francisco, Ca.

Rimal B. Bera, MD Page 18

168. Eastern Canada Private Practice Psychiatrists. “Critical Decision Making with the New Treatments for Psychosis” February 10, 2001. Mt. St. Tremblant, Quebec, Canada.

169. Mt. Vernon Mental Health Clinic. “Comparing the side effects of the Atypicals” February 21, 2001. Mt. Vernon, Washington.

170. Private Practice Psychiatrists-Northwest Washington. “Critical Decision Making with the Newer Antipsychotics” February 21, 2001. Bellingham, Washington.

171. Western State Hospital Department of Psychiatry. “Update on the Use of Seroquel” February 22, 2001. Tacoma, Washington.

172. American Lake VAMC Department of Psychiatry. “Use of the Atypicals Outside of Psychosis” February 22, 2001. American Lake, Washington.

173. Private Practice Psychiatrists in Seattle. “Maximizing Outcomes in Psychiatry with the New Agents for Psychosis” February 22, 2001. Seattle, Washington.

174. St. Peter’s Hospital Department of Psychiatry. “The Atypicals in the Acute Setting” February 23, 2001. Olympia, Washington.

175. Tacoma City Mental Health Center. “Outpatient Use of the Atypicals” February 23, 2001. Tacoma, Washington.

176. Fresno County Mental Health Department. “Update on Side Effects of the Atypicals” March 1, 2001. Fresno, Ca.

177. Patton State Hospital. “Initiating Treatment with Ziprasidone” March 7, 2001. Highland, Ca.

178. Valley Presbyterian Hospital Grand Rounds. “New Treatments in Alzheimers Disease” March 13, 2001. Van Nuys, Ca.

179. Merced County Mental Health Department. “Maximizing Outcomes in Psychosis” March 14, 2001. Merced, Ca.

180. Stockton City Private Practice Psychiatrists. “Differences Among the Atypicals” March 14, 2001. Stockton, Ca.

181. Redlands City Private Practice Psychiatrists. “Where Does Geodon Fit?” March 16, 2001. Redlands, Ca.

182. Orange County Psychiatric Society. Comparing Geodon with the other Atypicals” March 20, 2001. Newport Beach, Ca.

183. Orange County Private Practice Psychiatrists. “Maximizing Outcomes with Seroquel” March 22, 2001. Tustin, Ca.

184. Cook County Private Practice Psychiatrists. “Case Discussions with the Atypicals” March 26, 2001. Chicago, Ill.

185. Elgin County Mental Health Department Grand Rounds. “Critical Decision Making with the New Atypicals” March 27, 2001. Elgin, Ill.

Rimal B. Bera, MD Page 19

186. Alameda County Mental Health Department. “Cost Effectiveness of the New Atypicals” March 28, 2001. Oakland, Ca.

187. San Quentin Prison Department of Psychiatry. “The Use of the Atypicals in the Prison Setting” March 28, 2001. San Quentin, Ca.

188. Vacaville State Prison. “The Use of the Atypicals in the Acute Setting” March 29, 2001. Vacaville, Ca.

189. Sacramento County Department of Psychiatry. “Differences Among the Atypicals” March 29, 2001. Sacramento, Ca.

190. Bakersfield City Private Practice Psychiatrists. “Introduction to the Use of Ziprasidone” April 2, 2001. Bakersfield, Ca.

191. Cedars-Sinai Department of Psychiatry. “Update on Side Effects of the Atypicals” April 3, 2001. Beverly Hills, Ca.

192. Northeast Mental Health Center. “Maximimizing Outcomes with the New Atypicals” April 4, 2001. Los Angeles, Ca.

193. Denver VA Department of Psychiatry. “Update on Seroquel in the Acute Setting” April 5, 2001. Denver, Co.

194. Boulder City Private Practice Psychiatry. “Differences Among the Atypicals” April 5, 2001. Boulder, Co.

195. Denver Mental Health Clinic. “Roundtable Case Discussion on Psychosis” April 6, 2001. Denver, Co.

196. Denver Private Practice Psychiatrists. “Maximizing Outcomes in Schizophrenia” April 6, 2001. Denver, Co.

197. Lanterman State Hospital. “Use of the Atypical Antipsychotics in the Developmental Disordered Population” April 17, 2001. Pomona, Ca.

198. Los Angeles City Private Practice Psychiatrists. “Differences Among the Atypicals” April 17, 2001. Los Angeles, Ca.

199. Denver City Private Practice Psychiatrists. “Maximizing the Use of Seroquel in the Acute Setting” April 18, 2001. Denver, Co.

200. Orange County Private Practice Psychiatrists. “Clinical Focus on the Use of Ziprasidone” April 20, 2001. Costa Mesa, Ca.

201. Orange County Mental Health Department. “Clinical Applications of Geodon” May 2, 2001. Santa Ana, Ca.

202. Southern Nevada Psychiatric Society. “Maximizing the Use of Seroquel in the Acute Setting.” May 3, 2001. Las Vegas, Ne.

203. College Hospital Department of Psychiatry. “Clinical Use of Ziprasidone.” May 11, 2001. Costa Mesa, Ca.

204. South Bay Psychiatric Society. “Maximizing the Use of the Atypicals.” May 14, 2001. Torrance, Ca.

205. University of Southern California Department of Psychiatry. “Clinical Applications of Geodon” May 15, 2001. Los Angeles, Ca.

Rimal B. Bera, MD Page 20

206. Huntington Memorial Hospital. “Clinical Applications of The New Atypical” May 16, 2001. Pasadena, Ca.

207. Northwestern University Department of Psychiatry. “Maximizing the Use of the Atypicals in the Outpatient Setting” May 23, 2001. Chicago, Ill.

208. Private Practice Psychiatrists for Salt Lake City. “Maximizing the Use of the Atypicals in the Outpatient Setting” June 1, 2001. Sandy, Utah.

209. Harbor-UCLA Department of Psychiatry. “Clinical Applications of Geodon” June 5, 2001. Torrance, Ca.

210. San Diego County Private Practice Psychiatrists. “Differences Among the Atypicals” June 5, 2001. Del Mar, Ca.

211. Portland Oregon Private Practice Psychiatrists. “Differences Among the Atypicals” June 11, 2001. Portland, Or.

212. Burlingame Hospital Department of Psychiatry. “Maximizing Outcomes in Psychosis.” June 13, 2001. Burlingame, Ca.

213. Peoria Illinois Private Practice Psychiatrists. “Maximizing the Use of the Atypicals in the Outpatient Setting” June 19, 2001. Peoria, Illinois.

214. Baldwin Park Kaiser Department of Psychiatry. “The Differential Diagnosis and Treatment of Aggression.” June 26, 2001. Baldwin Park, Ca.

215. Arrowhead Regional Medical Center Department of Psychiatry. “Differences Among the Atypicals” July 17, 2001. Colton, Ca.

216. Cook County Hospital Department of Psychiatry. “The Use of the Atypicals in the Acute Setting.” August 17, 2001. Chicago, Ill.

217. Los Angeles County Jail Department of Psychiatry. “The Use of the Atypicals in the Acute Setting.” September 18, 2001. Los Angeles, Ca.

218. Tehachapi Prison Department of Psychiatry. “Maximizing Outcomes in Psychosis.” Lancaster, Ca. September 26, 2001.

219. Fontana Kaiser Department of Psychiatry. “PTSD: Diagnosis and Treatment.” Fontana, Ca. October 18, 2001.

220. Riverside County Private Practice Psychiatry. “Differentiating the SSRI’s.” Riverside, Ca. October 18, 2001.

221. Milwaukee VA Department of Psychiatry. “Differences Among the Atypicals” Milwaukee, Wi. November 14, 2001.

222. San Antonio State Hospital. “Differences Among the Atypicals” San Antonio, Texas. November 16, 2001.

223. Southern California Primary Care Physicians. “Differentiating the SSRI’s.” Newport Beach, Ca. December 8, 2001.

Rimal B. Bera, MD Page 21

224. University of Utah Department of Psychiatry. “Maximizing Outcomes in Psychosis.” Salt Lake City, Utah. December 10, 2001.

225. Iowa City VA Department of Psychiatry. “The Use of the Atypicals in the Non-Schizophrenic Population.” January 17, 2002.

226. Ventura County Psychiatric Hospital. “Maximizing the Atypicals in the Acute Setting.” January 22, 2002. Ventura, Ca.

227. Parkview Hospital. “The Appropriate Use of Restraints in the Medical Setting.” Riverside, Ca. February 5, 2002.

228. Nevada Family Practice Annual Meeting. “The Use of the Atypical Antipsychotics in the Non-Psychotic Population.” Reno, Nv. February 6, 2002.

229. Eugene VA Department of Psychiatry. “Maximizing the Outcomes with the Atypicals.” Eugene, Or. February 13, 2002.

230. Private Practice Psychiatrists-San Diego. “Maximizing the Role of Ziprasidone.” San Diego, Ca. February 21, 2002.

231. Martin Luther King Hospital Department of Psychiatry. “Maximizing the Atypicals in the Acute Setting.” Los Angeles, Ca. February 26, 2002.

232. San Mateo County Psychiatric Society. “The Use of the Atypicals Beyond Psychosis.” Redwood City, Ca. March 5, 2002.

233. Stockton General Hospital. “Differentiation of the SSRI’s.” Stockton, Ca. March 13, 2002.

234. Pharmacy Support Services Annual Meeting. “Treatment of Agitated Behaviors in Selected Resident Populations.” Long Beach, Ca. March 28, 2002.

235. Iowa VA Department of Psychiatry. “The Use of the Atypical Antipsychotics in the Non-Psychotic Population.” Iowa City, Iowa. April 3, 2002.

236. A.P.R.N. Monthly Meeting. “Maximizing Outcomes with Quetiapine.” Salt Lake City, Utah. April, 9, 2002.

237. Yankton VA Department of Psychiatry. “The Use of the Atypical Antipsychotics in the Non-Psychotic Population.” Yankton, South Dakota. April 17, 2002.

238. Travis Air Force Base Department of Psychiatry. “Optimizing Outcomes with Seroquel.” Travis Air Force Base, Ca. April 26, 2002.

239. Camp Pendleton Department of Psychiatry. “One Year Update of Ziprasidone.” Camp Pendleton Marine Base, Ca. May 2, 2002.

240. South Bend, Indiana Private Practice Psychiatrists. “The Use of the Atypical Antipsychotics in the Non-Psychotic Population.” South Bend, IN. May 16, 2002.

Rimal B. Bera, MD Page 22

241. Cedars-Sinai Department of Psychiatry. “The Use of the Atypical Antipsychotics in the Non-Schizophrenia Population.” Los Angeles, Ca. June 13, 2002.

242. University of Nevada, Reno Department of Psychiatry. “One Year Update on Ziprasidone.” June 19, 2002.

243. Olive View Medical Center Department of Psychiatry. “The Use of the Atypicals in the Acute Setting.” Sylmar, Ca. July 23, 2002.

244. Winnebago State Hospital. “The Use of the Atypical Antipsychotics in the Non-Schizophrenia Population.” Winnebago, Wi. July 24, 2002.

245. Central Oklahoma Psychiatric Society. “Augmentation Strategies in Schizophrenia.” Oklahoma City, Ok. August 15, 2002.

246. University of California, Irvine Department of Psychiatry. “Differences Among the Atypicals.” Orange, Ca. September 17, 2002.

247. Hemet General Hospital. “The Use of Atypicals in the Primary Care Setting.” Hemet, Ca. September 25, 2002.

248. Scripps Hospital Internal Medicine Department. “The Use of Atypicals in the Primary Care Setting.” San Diego, Ca. October 1, 2002.

249. Pomona General Hospital. “Treatment and Diagnosis of Depression.” Pomona, Ca. October 1, 2002.

250. North Valley Mental Health Clinic. “Differences Among the Atypicals.” Salt Lake City, Utah. October 9, 2002.

251. Rusk State Hospital. “The Use of the Atypical Antipsychotics in the Non-Schizophrenia Population.” Tyler, Texas. October 17, 2002.

252. Good Samaritan Hospital 1st Annual Psychiatric Symposium. “Maximizing Atypicals.” Englewood, Co. November 2, 2002.

253. Eastern State Hospital. “Augmentation Strategies in Schizophrenia.” Spokane, Wa. November 7, 2002.

254. Balboa Naval Hospital Department of Psychiatry. “Update on the Use of Ziprasidone.” San Diego, Ca. November 8, 2002.

255. APRN Monthly Meeting. “Off-Label Uses of the Atypicals.” Salt Lake City, Utah. December 3, 2002.

256. Private Practice Psychiatrists, Rajkot, India. “Psychopharmacology Update: New Emerging Treatment Strategies.” Rajkot, India. January 3, 2003.

257. University of Colorado Health Science Center Department of Psychiatry. “Strategies for Treating Psychosis.” Denver, Co. January 15, 2003.

258. Fort Logan Mental Health Hospital. “Augmentation Strategies in the Treatment of Psychosis.” Denver, Co. January 16, 2003.

Rimal B. Bera, MD Page 23

259. University of Washington Department of Psychiatry. “Maximizing Outcomes with the Atypicals.” Seattle, Wa. January 29, 2003.

260. Western State Hospital. “Maximizing Outcomes in the Treatment Refractory Population.” Tacoma, Wa. January 30, 2003.

261. Supelveda VA Department of Psychiatry. “The Etiology of Psychosis.” Supelveda, Ca. February 12, 2003.

262. South Bay Mental Health Center. “Differences Among the Atypicals.” Hawthorne, Ca. February 18, 2003.

263. Oklahoma University Department of Psychiatry. “Augmentation Strategies in the Treatment of Psychosis.” Oklahoma City, OK. February 20, 2003.

264. Elgin State Hospital. “Critical Decision Making with the Atypicals.” Elgin, Ill. February 25, 2003.

265. University of Utah Department of Psychiatry. “Critical Decision Making with the Atypicals.” Salt Lake City, Utah. March 4, 2003.

266. Private Practice Psychiatrists-Portland, Oregon. “Differences Among the Atypicals.” Portland, Oregon. March 10, 2003.

267. Austin State Hospital. “The Use of the Atypical Antipsychotics in the Non-Schizophrenia Population.” Austin, Texas. March 18, 2003.

268. University of Texas-San Antonio, Department of Psychiatry. “The Use of the Atypical Antipsychotics in the Non-Schizophrenia Population.” San Antonio, Texas. March 19, 2003.

269. Loma Linda VA Department of Psychiatry. “Critical Decision Making with the Atypicals.” Loma Linda, Ca. March 27, 2003.

270. Kaiser Permanente Sunset Department of Psychiatry. “The Use of the Atypical Antipsychotics in the Non-Schizophrenia Population.” Hollywood, Ca. April 1, 2003.

271. Nevada Correctional Facility. “Atypical Outcomes in the Forensic Setting.” Carson City, Nevada. April 7, 2003.

272. Northern California Psychiatric Society-North Bay Chapter. “Critical Decision Making with the Atypicals.” Napa, Ca. April 11, 2003.

273. Private Practice Psychiatrists-Des Moines, Iowa. “The Use of the Atypical Antipsychotics in the Non-Schizophrenia Population.” Des Moines, Iowa. April 15, 2003.

274. University of Wisconsin Department of Psychiatry. “Critical Decision Making with the Atypicals.” Madison, Wi. April 23, 2003.

275. Los Angeles Metropolitan Hospital. “Critical Decision Making with the Atypicals.” Los Angeles, Ca. April 30, 2003.

Rimal B. Bera, MD Page 24

276. Palo Alto VA Department of Psychiatry. “Differences Among the Atypicals.” Palo Alto, Ca. May 7, 2003.

277. Wausau General Hospital Department of Psychiatry. “Critical Decision Making with the Atypicals.” Wausau, Wi. May 12, 2003.

278. Oklahoma University Department of Psychiatry. “Treatment of Agitation in the Psychotic Patient.” Oklahoma City, OK. May 29, 2003.

279. Central Oklahoma Psychiatric Society. “Critical Decision Making with the Atypicals: Finding the Right Fit for each Patient.” Oklahoma, City, OK. May 29, 2003.

280. Oklahoma University Department of Psychiatry. “Critical Decision Making with the Atypicals.” Tulsa, OK. June 4, 2003.

281. Eastern State Forensic Center. “The Use of the Atypical Antipsychotics in the Forensic Population.” Vinita, OK. June 5, 2003.

282. Pioneer Medical Group. “The Psychology of Pain: Evaluation and Treatment.” Costa Mesa, Ca, June 7, 2003.

283. Eastern Louisiana Mental Health Center. “Critical Decision Making with the Atypicals: “Finding the Right Fit for Each Patient.” Jackson, LA. June 9, 2003.

284. Central State Psychiatric Hospital. “The Use of the Atypical Antipsychotics in the State Hospital Population.” Alexandria, LA. June 13, 2003.

285. Astra-Zeneca Regional Advisory Board. “Maximizing Outcomes with Quetiapine.” Austin, Texas. June 21, 2003.

286. St. Cloud VA Department of Psychiatry. “The Use of the Atypical Antipsychotics in the VA Population.” St. Cloud, Minn. June 26, 2003.

287. University of Minnesota Department of Psychiatry. “The Use of Atypical Antipsychotics: Finding the Right Fit for Each Patient.” Minneapolis, Minn. June 27, 2003.

288. Downtown Los Angeles Mental Health Clinic. “Critical Decision Making with the Atypicals.” Los Angeles, Ca. July 18, 2003.

289. Waco VA Department of Psychiatry. “The Use of the Atypical Antipsychotics in Special Populations.” Waco, Texas. July 22, 2003.

290. Los Angeles County Central Jail. “The Use of the Atypical Antipsychotics in the Forensic Population.” Los Angeles, Ca. July 23, 2003.

291. Houston VA Department of Psychiatry. “Expanding the Horizons on the Applications of the Atypical Antipsychotics.” Houston, Texas. August 7, 2003.

Rimal B. Bera, MD Page 25

292. North Dakota State Hospital. “The Use of the Atypical Antipsychotics in the State Hospital Population.” Jamestown, North Dakota. August 13, 2003.

293. University of Southern California Department of Psychiatry. “Critical Decision Making with the Atypicals.” Los Angeles, California. August 21, 2003.

294. Kaiser Permanente Department of Family Practice. “Differentiating the SSRI’s.” Newport Beach, California. August 28, 2003.

295. University of California, Irvine Department of Psychiatry. “Critical Decision Making with the Atypicals.” Orange, California. September 2, 2003.

296. Waco VA Department of Psychiatry. “The Use of the Atypical Antipsychotics in the VA Population.” Waco, Texas. September 4, 2003.

297. Kern County Psychiatric Society. “The Use of Atypical Antipsychotics in Bipolar Affective Disorder.” Bakersfield, California. September 9, 2003.

298. Metropolitan State Hospital. “Critical Decision Making with the Atypicals.” Norwalk, California. September 10, 2003.

299. American Academy of Clinical Psychiatrists. “GABA and Glutamate: What are their roles in Psychosis.” Chicago, Illinois. October 10, 2003.

300. San Antonio VA Department of Psychiatry. “The Use of the Atypical Antipsychotics in the VA Population.” San Antonio, Texas, October 16, 2003.

301. Regent’s Pointe Elderly Residence. “The Latest Treatments in Memory Disturbance.” Irvine, California. October 22, 2003.

302. Southside Mental Health Clinic. “Critical Decision Making with the Atypicals.” Milwaukee, Wisconsin. October 29, 2003.

303. Hennepin County Medical Center Department of Psychiatry. “Critical Decision Making with the Atypicals.” Minneapolis, Minnesota. November 7, 2003.

304. Private Practice Physicians. “Treatment of Agitation in the Emergency Setting.” Vienna, Virginia. November 12, 2003.

305. Hawaii Psychiatrists CME Update. “The Use of Atypical Antipsychotics in Bipolar Affective Disorder.” Honolulu, Hawaii. November 15, 2003.

306. Iowa Veteran’s Home. “Delirium in the Long Term Care Setting.” Marshalltown, Iowa. November 21, 2003.

307. Maricopa County Mental Health Center. “The Use of Atypical Antipsychotics in Bipolar Affective Disorder.” Phoenix, Arizona. January 8, 2004.

Rimal B. Bera, MD Page 26

308. San Bernardino County Mental Health. “Update on the Use of Depakote in Psychiatry.” Rancho Cucamonga, Ca. January 14, 2004.

309. St. Joseph’s Hospital Department of Psychiatry. “The Use of Long-Acting Injectible Antipsychotics.” Orange, Ca. January 16, 2004.

310. California Pacific Medical Center Department of Psychiatry. “The Use of Atypical Antipsychotics in Bipolar Affective Disorder.” San Francisco, Ca. January 20, 2004.

311. Napa State Hospital Department of Psychiatry. “New Concepts in the Treatment of Refractory Bipolar Disorder.” Napa, Ca. January 22, 2004.

312. Searcy State Hospital. “Critical Decision Making with the Atypicals: A Focus on Mood and Psychotic Disorders.” Mt. Vernon, Alabama. January 27, 2004.

313. Milan Forensic Center. “The Use of Atypical Antipsychotics in the Forensic Setting.” Milan, Michigan. February 4, 2004.

314. Chino Men’s Prison. “Update on the Use of Depakote in Psychiatry.” Chino, Ca. February 10, 2004.

315. University of Southern California Department of Psychiatry. “Maximizing the Use of the Atypicals in the Acute Setting.” Rosemead, Ca. February 12, 2004.

316. Kaiser Fontana Department of Family Medicine. “2004 Update on the Diagnosis and Treatment of Schizophrenia.” Fontana, Ca. February 17, 2004.

317. University of Iowa Department of Psychiatry. “Critical Decision Making with the Atypicals: A Focus on Mood and Psychotic Disorders.” Iowa City, Iowa. February 24, 2004.

318. San Francisco General Hospital Department of Psychiatry. “The Use of Atypical Antipsychotics in Bipolar Affective Disorder.” San Francisco, Ca. February 27, 2004.

319. Waukesha County Mental Health Center. “Critical Decision Making with the Atypicals: A Focus on Mood and Psychotic Disorders.” Waukesha, Wisconsin. March 4, 2004.

320. Los Angeles County Outpatient Parole Clinic. “Use of Atypical Antipsychotics in the Forensic Population.” Los Angeles, Ca. March 10, 2004.

321. Northeast Mental Health Clinic. “Critical Decision Making with the Atypicals: A Focus on Mood and Psychotic Disorders.” Los Angeles, Ca. March 11, 2004.

322. St Joseph’s Hospital Department of Medicine. “Update on the Diagnosis and Treatment of Schizophrenia.” Orange, Ca. March 12, 2004.

Rimal B. Bera, MD Page 27

323. Riverside County Mental Health. “The Use of Atypical Antipsychotics in Bipolar Affective Disorder.” Riverside, Ca. March 18, 2004.

324. Kaiser Permanente Department of Medicine. “Update on the Diagnosis and Treatment of Anxiety Disorders.” Irvine, Ca. March 18, 2004.

325. Seattle Mental Health Center. “Critical Decision Making with the Atypicals: A Focus on Mood and Psychotic Disorders.” Bellevue, Wa. April 7, 2004.

326. Christ Advocate Hospital Department of Psychiatry. “Best Treatments for Acute Exacerbation of Psychotic Illnesses.” Chicago, Illinois. April 14, 2004.

327. Veteran’s Home Department of Psychiatry. “Critical Decision Making with the Atypicals: A Focus on Mood and Psychotic Disorders.” Yountville, Ca. April 16, 2004.

328. Glendale Adventist Hospital Department of Psychiatry. “Shortening the Length of Stay in Acute Settings of Behavioral Health.” Glendale, Ca. April 19, 2004.

329. Birmingham Alabama Society of Family Medicine. “Update on the Diagnosis and Treatment of Schizophrenia and Bipolar Disorder.” Birmingham, Alabama. April 24, 2004.

330. Pensacola Mental Health Center. “Critical Decision Making with the Atypicals: A Focus on Mood and Psychotic Disorders.” Pensacola, Florida. May 10, 2004.

331. Chico Mental Health Clinic. “Critical Decision Making with the Atypicals: A Focus on Mood and Psychotic Disorders.” Chico, Ca. May 20, 2004.

332. Oregon State Hospital. “Optimizing Outcomes in the State Hospital Setting.” Salem, Oregon. May 24, 2004.

333. Harris County Psychiatric Center. “Critical Decision Making with the Atypicals: A Focus on Mood and Psychotic Disorders.” Houston, Texas. June 3, 2004.

334. University of Texas, Houston Department of Psychiatry. “Maximizing Outcomes with the Atypicals.” Houston, Texas. June 4, 2004.

335. Wyoming State Hospital. “Optimizing Outcomes with the Atypical Antipsychotics in the State Hospital Setting.” Evanston, Wyoming. June 8, 2004.

336. Weber County Human Services. “Critical Decision Making with the Atypicals: A Focus on Mood and Psychotic Disorders.” Ogden, Utah. June 9, 2004.

337. Kaiser Permanente Department of Psychiatry. “Use of Novel Adjunctive Strategies to Improve Outcomes in Psychosis.” Union City, Ca. June 16, 2004.

Rimal B. Bera, MD Page 28

338. Patton State Hospital. “Improving Outcomes in Psychosis: A Six Month Update on the First Long Acting Injectible Atypical Antipsychotic.” San Bernardino, Ca. June 17, 2004.

339. Citrus Valley Medical Center. “Advances in the Management of Acute Agitation From the Emergency Room Setting To Discharge.” Covina, Ca. July 6, 2004.

340. Swedish Covenant Medical Center. “Advances in the Management of Acute Agitation From the Emergency Room Setting To Discharge.” Chicago, Ill. July 7, 2004.

341. Central California Psychiatric Society. “Critical Decision Making with the Atypicals: A Focus on Mood and Psychotic Disorders.” Fresno, Ca. July 13, 2004.

342. Boston MA CME Inc Program. “Update on the Management of Bipolar Depression.” Boston, Ma. July 31, 2004.

343. Antelope Valley Hospital Department of Psychiatry. “A 2004 Update on the Treatment and Management of Bipolar Disorder.” Lancaster, Ca. August 5, 2004.

344. Shasta County Mental Health Center. “Advances in the Management of Acute Agitation From the Emergency Room Setting To Discharge.” Redding, Ca. August 11, 2004.

345. University of California, Irvine, Department of Psychiatry Grand Rounds. “Maximizing Outcomes with the Atypicals in the Acute Setting.” Orange, Ca. August 31, 2004.

346. Atascadero State Hospital. “Use of Novel Adjunctive Strategies to Improve Outcomes in Psychosis.” Atascadero, Ca. October 13, 2004.

347. California Society for Hospital Pharmacists Annual Meeting. “Update on Diagnosis and Treatment of Bipolar Disorder.” Long Beach, Ca. November 5, 2004.

348. Private Practice Psychiatry. “Update on Diagnosis and Treatment of Bipolar Disorder with Atypicals.” Berkeley, California. January 19, 2005.

349. Fairview Developmental Center Medical Staff. “The Use of Atypical Antipsychotics in the Developmentally Disabled Population.” Costa Mesa, Ca. January 20, 2005.

350. Private Practice Psychiatry. “Maximizing Outcomes with the Atypicals.” Lake Charles, Louisiana. February 17, 2005.

351. Travis Air Force Base Department of Mental Health. “The Use of Atypicals in Mood Disorders.” Travis, Ca. March 4, 2005.

352. Kaiser Permanente Department of Medicine. “Maximizing Outcomes in Alzheimer’s Disease.” Orange, Ca. March 9, 2005.

353. Los Angeles County-University of Southern California Department of Psychiatry. “Update on the Diagnosis and

Rimal B. Bera, MD Page 29

Treatment of Bipolar Disorder.” Los Angeles, Ca. March 24, 2005.

354. Rush Medical School Department of Psychiatry. “Maximizing Outcomes with the Atypicals.” Chicago, Illinois. April 7, 2005.

355. San Antonio Community Hospital Department of Medicine. “Maximizing Outcomes in Alzheimer’s Disease.” Upland, Ca. April 28, 2005.

356. Riverside County Mental Health. “Maximizing Outcomes with the Atypicals.” Riverside, Ca. May 19, 2005

357. Metropolitan State Hospital. “Update on Treatment Refractory Schizophrenia” Norwalk, Ca. June 5, 2005.

358. Fresno County Mental Health Department. “Maximizing Outcomes with Ziprasidone in Mood and Psychotic Disorders.” Fresno, Ca. July 6, 2005.

359. Los Angeles County Jail. “Maximizing Outcomes with the Atypicals in the Forensic Setting.” Los Angeles, Ca. August 16, 2005.

360. Optimum Care Consutling Pharmacists. “Update on the New Agents for Bipolar Disorder.” Anaheim, Ca. September 1, 2005.

361. Rancho Los Amigos Hospital Department of Medicine. “New Concepts in the Treatment of Bipolar Disorder.” Downey, Ca. September 1, 2005.

362. Central California Psychiatric Society. “The Use of Quetiapine in Bipolar Affectice Disorder” Bakersfield, Ca. September 8, 2005.

363. Huntington Beach Hospital. “Maximizing Outcomes with the Atypicals in the ER Setting.” Huntington Beach, Ca. September 15, 2005.

364. Brown County Department of Mental Health. “Use of Novel Adjunctive Strategies to Improve Outcomes in Psychosis.” Green Bay, Wisconsin. September 21, 2005.

365. Kaiser Permanente Department of Internal Medicine. “The Diagnosis and Treatment of Alzheimer’s Disease.” Santa Ana, Ca. September 22, 2005.

366. Victorville Federal Penitentiary. “The Use of Atypicals in the Prison Setting.” Victorville, Ca. October 26, 2005.

367. Centinela Hospital Department of Medicine. “New Concepts in the Treatment of Bipolar Disorder.” Inglewood, Ca. November 1, 2005.

368. McMaster University Department of Psychiatry. “New Concepts in the Treatment of Schizophrenia.” Hamilton, Ontario, Canada. November 10, 2005.

Rimal B. Bera, MD Page 30

369. Riverside County Mental Health. “An Ethnopsychopharmacological Approach to Use of the Atypicals” Riverside, Ca. November 17, 2005.

370. County Of Monterey Mental Health Services. “Use of Novel Adjunctive Strategies to Improve Outcomes in Psychosis.” Monterey, Ca. December 8, 2005.

371. Orange County Jail. “Use of Novel Adjunctive Strategies to Improve Outcomes in Psychosis in the Forensic Setting.” Santa Ana, Ca. January 25, 2006.

372. Private Practice Psychiatry. “Maximizing Outcomes with the Atypicals.” Houston, Texas. January 26, 2006.

373. Fairview Developmental Center. “Use of Atypicals in the Developmentally Disabled Population.” Costa Mesa, Ca. January 31, 2006.

374. White Memorial Hospital Medical Staff. “Update on the Diagnosis and Treatment of Bipolar Disorder.” Las Cruces, New Mexico. February 1, 2006.

375. St. Mary’s Hospital Medical Staff. “Update on the Diagnosis and Treatment of Bipolar Disorder.” Reno, Nevada. February 2, 2006.

376. Aurora Hospital Medical Staff. “Update on the Diagnosis and Treatment of Bipolar Disorder.” Aurora, Colorado. February 3, 2006.

377. Fountain Valley Hospital Medical Staff. “Maximizing Outcomes in Mood Disorders.” Fountain Valley, Ca. February 10, 2006.

378. Kedren Mental Health Center Department of Psychiatry. “Interpreting the Results of the CATIE Study.” Los Angeles, Ca. February 13, 2006.

379. San Francisco General Hospital Department of Psychiatry. “Maximizing Outcomes in Bipolar Depression.” San Francisco, Ca. February 17, 2006.

380. Olive View-UCLA Department of Psychiatry. “Neurobehavioral Disorders: Diagnosis and Treatment.” Sylmar, Ca. March 2, 2006.

381. Pri-Med Primary Care Conference. “Update on the Diagnosis and Treatment of Bipolar Affective Disorder.” Seattle, Wa. March 3, 2006.

382. Irvine Regional Hospital Medical Staff. “Update on the Diagnosis and Treatment of Bipolar Disorder.” Irvine, Ca. March 8, 2006.

383. Sharp Grossmont Hospital Medical Staff. “Alzheimer’s Disease: An Update on Diagnosis and Treatment.” La Mesa, Ca. March 10, 2006.

Rimal B. Bera, MD Page 31

384. Private Practice Psychiatry. “Critical Analysis of the CATIE Trial.” St. Louis, Missouri. March 14, 2006.

385. Private Practice Psychiatry. “Critical Analysis of the CATIE Trial.” Little Rock, Ark. March 15, 2006.

386. Private Practice Psychiatry. “Critical Analysis of the CATIE Trial.” Riverside, Ca. March 16, 2006.

387. Loyola University Department of Psychiatry. “Maximizing Outcomes with the Atypicals.” Chicago, Ill. March 30, 2006.

388. Private Practice Psychiatry. “Critical Analysis of the CATIE Trial.” Miami, Fl. March 23, 2006.

389. Transitional Living Services Department of Psychiatry “Update on the Diagnosis and Treatment of Bipolar Disorder.” Milwaukee, Wi. April 12, 2006.

390. Pacific Hospital Department of Medicine. “Maximizing Outcomes in Affective Disorder.” Long Beach, CA. April 25, 2006.

391. Monterey Park Hospital. “New Concepts in Bipolar Disorder.” Monterey Park, Ca. May 2, 2006.

392. Montclair Hospital Grand Rounds. “Phobias: Diagnosis and Treatment.” Montclair, Ca. May 4, 2006.

393. Pri-Med Update.“Update on the Diagnosis and Treatment of Bipolar Affective Disorder.” Toledo, Ohio. May 11, 2006.

394. Pri-Med Update.“Update on the Diagnosis and Treatment of Bipolar Affective Disorder.” Norfolk, Va. May 12, 2006.

395. Mental Health Association Annual Meeting of the Minds. “Pros and Cons of Clinical Research.” Anaheim, Ca. May 18, 2006.

396. West Valley Mental Health Center. “Maximizing Outcomes with the Atypicals.” Salt Lake City, Utah. May 25, 2005.

397. St. Vincent’s Hospital Department of Medicine. “Update on the Diagnosis and Treatment of Bipolar Affective Disorder.” Los Angeles, Ca. June 15, 2006.

398. Mission Mental Health Clinic. “Maximizing Outcomes with the Atypicals.” San Francisco, Ca. June 21, 2006.

399. Parole Office. “Maximizing Outcomes in the Forensic Setting.” Los Angeles, Ca. June 28, 2006.

400. Provo Mental Health Clinic. “Bipolar Depression.” Provo, Utah. July 26, 2006.

401. University of California, Irvine, Department of Psychiatry. “Maximizing Outcomes in Bipolar Disorder: A Focus on Bipolar Depression.” Orange, Ca. August 1, 2006.

402. Hollywood Mental Health Center. “Update on the Diagnosis and Treatment of Bipolar Disorder.” Hollywood, Ca. August 30, 2006.

Rimal B. Bera, MD Page 32

403. Fairfield Hospital. “The Impaired Physician.” Fairfield, Ca. September 11, 2006.

404. Penn Foundation. “Update on the Diagnosis and Treatment of Bipolar Disorder.” Sellersville, Pa. September 13, 2006.

405. Alvarado Hospital Department of Medicine. “Update on the Diagnosis and Treatment of Major Depression and Bipolar Disorder.” San Diego, Ca. September 19, 2006.

406. Lakewood Hospital Medical Center. “Personality Disorders.” Lakewood, Ca. September 22, 2006.

407. Parkview Hospital. “Suicide Assessment and Prevention.” Riverside, Ca. February 6, 2007.

408. St. Vincent’s Hospital. “Psychiatric Assessment for the Primary Care Physician.” Los Angeles, Ca. February 15, 2007.

409. Salinas Valley Medical Center. “Update on the Treatment of Depression.” Salinas, Ca. February 27, 2007.

410. Long Beach VA. “Treatment of the Aggressive Patient.” Long Beach, Ca. March 7, 2007.

411. San Jose Regional Medical Center. “Rapidly Progressive Dementia.” San Jose, Ca. March 13, 2007.

412. Spokane Valley Medical Center. “Bipolar, Suicide and Depression.” Spokane Valley, WA. March 27, 2007.

413. University of California, Irvine Department of Psychiatry. “Understanding the STAR-D Trial” Orange, Ca. April 3, 2007.

414. Palm Springs Medical Center. “Maintenance Treatment in Bipolar Depression” Palm Springs, Ca. April 4, 2007.

415. Syracuse New York Psychiatry. “Review of CATIE Program.” Syracuse, NY. April 17, 2007.

416. Rochester New York Psychiatry. “Review of CATIE Program.” Rochester, NY. April 18, 2007.

417. Buffalo Psychiatric Center. “Update on Treatment of Neurobehavioral Disorders.” Buffalo, NY. April 19, 2007.

418. Buffalo New York Psychiatry. “Review of CATIE Program.” Buffalo, NY. April 19, 2007.

419. Seattle Washington Psychiatry. “Review of CATIE Program.” Seattle, Wa. April 25, 2007.

420. Tampa Florida Psychiatry. “Review of CATIE Program.” Sarasota, Fl. April 30, 2007.

421. Encino-Tarzana Regional Medical Center. “Treatment with Mood Stabilizers and Safety Issues.” Encino, Ca. May 1, 2007.

422. San Antonio Texas Psychiatry. “Review of CATIE Program.” San Antonio, Tx. May 2, 2007.

423. Chicago, Illinois Psychiatry. “Review of CATIE Program.” Chicago, Ill. March 3, 2007.

Rimal B. Bera, MD Page 33

424. Orange County Alliance for Mentally Ill. “New Psychosocial Interventions for the Treatment of Schizophrenia.” Huntington Beach, Ca. May 10, 2007.

425. Denver, Colorado Psychiatry. “Issues in Adherence with Psychotropic Medications.” Denver, Co. May 14, 2007.

426. Springfield, Missouri Psychiatry. “Review of CATIE Program.” Springfield, Mo. May 29, 2007.

427. San Diego, California Psychiatry. “Maximizing Outcomes in Bipolar Depression.” San Diego, Ca. June 7, 2007.

428. Philadelphia, Pennsylvania Psychiatry. “Review of CATIE Program.” Philadelphia, Pa. June 11, 2007.

429. Creighton University Department of Psychiatry. “Review of CATIE Program.” Omaha, Ne. June 14, 2007.

430. Beverly Hospital. “Postpartum Depression.” Montebello, Ca. June 20, 2007.

431. Tulsa, Oklahoma Psychiatry. “Review of CATIE Program.” Tulsa, Ok. June 25, 2007.

432. Garden Grove Hospital. “Suicide Risk Assessment.” Garden Grove, Ca. June 26, 2007.

433. Osawatomie State Hospital. “New Treatments in Refractory Psychosis.” Osawatomie, Ks. July 9, 2007.

434. Lakewood Hospital Medical Center. “Diagnosing Refractory Depression.” Lakewood, Ca. January 25, 2008.

435. Riverside General Hospital. “Physician Well-Being.” Riverside, Ca. February 5, 2008.

436. Anaheim Memorial Hospital. “Suicide Risk Assessment.” Anaheim, Ca. February 19, 2008.

437. Metropolitan State Hospital. “Optimizing Outcomes in Treatment Refractory Psychosis.” Norwalk, Ca. February 20, 2008.

438. Alvarado Hospital. “Mood Disorders in the Primary Care Setting.” San Diego, Ca. March 26, 2008.

439. Fountain Valley Regional Hospital. “Alzheimer’s Disease.” Fountain Valley, Ca. April 4, 2008.

440. Portland, Oregon Private Practice Psychiatry. “New Options in Treatment of Psychosis.” Portland, Or. April 16, 2008.

441. Lincoln, Nebraska Private Practice. “Maximizing Outcomes in Bipolar Depression.” Lincoln, NE. May 15, 2008.

442. Western Maryland Medical Center. “Improving Adherence in Psychiatric Disorders.” Cumberland, MD. September 23, 2008.

443. Baptist Medical Center. “Improving Adherence in Psychiatric Disorders.” Little Rock AK. October 22, 2008.

444. Good Samaritan Medical Center. “Smoking Cessation.” Los Angeles, CA. January 7, 2009.

Rimal B. Bera, MD Page 34

445. Citrus Valley Medical Center. “Memory Loss and Prevention.” Los Angeles, CA. January 27, 2009.

446. Ogdensburg Medical Center. “Improving Adherence in Psychiatric Disorders.” Ogdensburg, NY. January 29, 2009.

447. San Clemente Medical Center. “Mental Incompetence.” San Clemente, CA. February 5, 2009.

448. Torrance Memorial Hospital. “Suicide Risk Assessment.” Torrance, Ca. February 11, 2009.

449. Northridge Community Hospital. “Atypical Antipsychotics.” Northridge, CA. March 3, 2009.

450. San Francisco Private Practice Psychiatrists. “New Treatments in Bipolar Depression.” San Francisco, CA March 5, 2009.

451. Salt Lake City Private Practice Psychiatrists. “New Treatments in Bipolar Depression.” Salt Lake City, UT March 18, 2009.

452. White Memorial Medical Center. “Physician Impairment.” Los Angeles, CA. March 26, 2009.

453. St. Judes Medical Center. “Physician Impairment.” Fullerton, CA. March 31, 2009.

454. Phoenix Private Practice Psychiatrists. “New Treatments in Bipolar Depression.” Phoenix, AZ April 1, 2009.

455. Evansville Private Practice Psychiatrists. “New Treatments in Bipolar Depression.” Evansville, IN. April 15, 2009.

456. Ann Arbor Private Practice Psychiatrists. “New Treatments in Bipolar Depression.” Ann Arbor, MI. April 16, 2009.

457. San Diego Private Practice Psychiatrists. “New Treatments in Bipolar Depression.” San Diego, CA. April 23, 2009.

458. Sacramento Private Practice Psychiatrists. “New Treatments in Bipolar Depression.” Sacramento, CA. April 30, 2009.

459. Kedren Medical Center. “New Treatments in Schizophrenia.” Los Angeles, CA. May 4, 2009.

460. Olive View Medical Center. “Bipolar, Suicide and Depression.” Sylmar, CA. May 7, 2009.

461. Honolulu Private Practice Psychiatrists. “New Treatments in Bipolar Depression.” Honolulu, HI. May 14, 2009.

462. Houston Private Practice Psychiatrists. “New Treatments in Bipolar Depression.” Houston, TX. June 10, 2009.

463. UCI Family Medicine Seminar. “Primary Care Treatment of Depression.” Anaheim, CA. June 23, 2009.

464. Santa Ana Mental Health Clinic. “New Treatments in Schizophrenia.” Santa Ana, CA. July 29, 2009.

465. Chicago Private Practice Psychiatrists. “New Treatments in Bipolar Depression.” Chicago, IL. August 6, 2009.

466. Fountain Valley Medical Center. “Physician Well-Being.” Fountain Valley, CA. September 11, 2009.

Rimal B. Bera, MD Page 35

467. Whittier Hospital. “Depression and Suicide.” Whittier, CA. September 17, 2009.

468. Good Samaritan Hospital. “Suicide Risk Assessment.” Los Angeles, CA. September 23, 2009.

469. Mission Hospital. “Smoking Cessation.” Mission Viejo, CA. January 6, 2010.

470. Anaheim Regional Medical Center. “Drug Abuse.” Anaheim, Ca. January 12, 2010.

471. Metropolitan State Hospital. “Update on New Antipsychotics.” Norwalk, CA. January 26, 2010.

472. Parkview Hospital. “Suicide Risk Assessment.” Riverside, CA. February 2, 2010.

473. Patton State Hospital. “Update on New Antipsychotics.” Highland, CA. February 9, 2010.

474. Kaiser Hospital. “Treatment Resistant Depression.” Ontario, CA. March 11, 2010.

475. Kaiser Clinic. “Update on New Antipsychotics.” Tustin, CA. March 18, 2010.

476. Riverside County Mental Health Clinic. “Update on New Antipsychotics.” Riverside, CA. March 25, 2010.

477. Kaiser Hospital. “Treatment Resistant Depression.” Harbor City, CA. April 29, 2010.

478. Chicago Private Practice Psychiatrists. “New Adjunctive Treatments in Unipolar Depression.” Chicago, Il. May 6, 2010.

479. Pasadena Private Practice Psychiatrists. “Treatment Resistant Depression.” Pasadena, CA. May 12, 2010.

480. Tacoma Private Practice Psychiatrists. “New Adjunctive Treatments in Unipolar Depression.” Tacoma, WA. May 18, 2010.

481. Gardena Hospital. “Suicide Risk Assessment.” Gardena, CA. June 8, 2010.

482. New Orleans Private Practice Psychiatrists. “New Adjunctive Treatments in Unipolar Depression.” New Orleans, LA. June 25, 2010.

483. Laureate Clinic. “New Adjunctive Treatments in Unipolar Depression.” Tulsa, OK. July 14, 2010.

484. San Jose Private Practice Psychiatrists. “New Adjunctive Treatments in Unipolar Depression.” Saratoga, CA. July 22, 2010.

485. Colorado Springs Private Practice Psychiatrists. “New Adjunctive Treatments in Unipolar Depression.” Colorado Springs, CO. July 27, 2010.

486. University of California, Irvine Department of Family Medicine. “New Atypical Antipsychotics.” Santa Ana, CA. November 13, 2010.

Rimal B. Bera, MD Page 36

487. Metropolitan State Hospital. “The Newest Treatment Options for Schizophrenia.” Norwalk, CA, December 11, 2010.

488. Centinela Hospital Medical Center. “Evaluation of Substance Abuse.” Inglewood, CA. January 25, 2011.

489. Sherman Oaks Medical Center. “Evaluation and Treatment of the Drug-Seeking Patient.” Sherman Oaks, CA. February 17, 2011.

490. Citrus Valley Medical Center. “Effective Communication with Difficult Patients.” Azuza, CA. March 15, 2011.

491. St. Francis Medical Center. “Update on the Treatment of Depression in the Primary Care Setting.” Lynwood, CA March 23, 2011.

492. Pacifica Hospital. “Common Psychiatric Conditions.” Sun Valley, CA April 7, 2011.

493. Daemon Medical Center. “Physician Impairment.” Stockton, CA. May 13, 2011.

494. Providence Hospital. “Physician Well-Being.” Burbank, CA. May 20, 2011.

495. Pioneer Medical Group. “Management of the Drug Seeking Patient.” Lakewood, Ca. June 23, 2011.

496. Redlands Community Private Practice Psychiatry. “New Treatments in Bipolar Disorder.” Redlands, Ca. January 20, 2012.

497. St. Francis Medical Center. “Evaluation of Depression in the Primary Care Setting.” Lynwood, CA. January 25, 2012.

498. Kedren Medical Center. ‘New Treatments in Schizophrenia.” Los Angeles, Ca. January 30, 2012.

499. Western Medical Center, Anaheim. “Evaluation of Suicide Risk.” February 10, 2012. Anaheim, Ca.

500. Orange County Private Practice Psychiatry. “A New Approach to Psychosis.” Anaheim, Ca. February 16, 2012.

501. Desert Community Health Center. “evaluation of the Disruptive Physician.” Victorville, Ca. February 28, 2012.

502. Scripps Medical Center. “Update on Dementia.” San Diego, Ca. March 20, 2012.

503. Hollywood Presbyterian Hospital. “Suicide Prevention.” Hollywood, Ca. March 23, 2012.

504. Valley Medical Center. “Maximizing Outcomes in Depression.” Van Nuys Medical Center. April 4, 2012.

505. Henry Mayo Medical Center. “Behavioral Management of Agitation.” Newhall, Ca. April 19, 2012.

506. John F. Kennedy Medical Center. “PTSD.” Indio, Ca. April 25, 2012.

507. St. Francis Hospital. “Physician Depression and Suicide.” Lynwood, Ca. May 9, 2012.

Rimal B. Bera, MD Page 37

508. Riverside County Mental Health. “New Treatments in Schizophrenia.” Riverside, Ca. May 16, 2012.

509. Rancho Los Amigos Hospital. “PTSD.” Downey, Ca. June 7, 2012.

510. San Bernardino County Mental Health. “Refractory Schizophrenia.” San Bernardino, Ca. June 14, 2012.

511. Patton State Hospital. “New Treatments in Schizophrenia.” Highland, Ca. June 20, 2012.

512. Central California Psychiatric Society. “Bipolar Depression.” Bakersfield, Ca. July 17, 2012.

513. St Joseph’s Hospital. “A New Treatment in Depression.” Orange, Ca. August 2, 2012.

514. Citrus Valley Medical Center. “Depression in the Primary Care Setting.” Covina, Ca. September 18, 2012.

515. Fountain Valley Regional Medical Center. “Management of Psychiatric Patients in the Acute Setting.” Fountain Valley, Ca. September 27, 2012.

516. John Henry Foundation. “Neurobiology of Schizophrenia.” Santa Ana, Ca. October 24, 2012.

517. Tarzana Medical Center. “Physician Stress.” Tarzana, Ca. November 9, 2012.

518. Northridge Hospital Medical Center. “PTSD.” Northridge, Ca. November 14, 2012.

519. Metropolitan State Hospital. “New Treatments in Schizophrenia.” Norwalk, Ca. January 16, 2013.

520. Ventura County Medical Center. “PTSD and Brain Trauma.” Ventura, Ca. January 23, 2013.

521. Western Medical Center. “Physician Burnout.” Santa Ana, Ca. February 11, 2013.

522. UCI Dept. of Family Medicine. “Evaluation of Suicide.” Santa Ana, Ca. February 21, 2013.

523. Henry Mayo Hospital. “PTSD.” Valencia, Ca. April 18, 2013. 524. San Bernardino Medical Center. “Physician Burnout.” San

Bernardino, Ca. May 2, 2013. 525. Glendale Adventist Medical Center. “Physician Well Being.”

Glendale, Ca. June 5, 2013. 526. Long Beach Community Mental Health. “New Treatments to

Decrease Hospitalizations in Schizophrenia.” Long Beach, Ca. June 26, 2013.

527. San Dimas Community Hospital. “Mental Health Evaluations in the Primary Care Setting.” San Dimas, Ca. July 16, 2013.

528. Chino Valley Hospital. “Depression Evaluations.” Chino Valley, Ca. July 25, 2013.

529. UCI Extension Course. “Mental Health System in the United States.” Irvine, Ca. August 9, 2013.

Rimal B. Bera, MD Page 38

530. Baton Rouge Mental Health Center. “Misconceptions with Long Acting Injectibles.” Baton Rouge, La. August 15, 2013.

531. Indian-American Psychiatry Association. “Misconceptions with Long Acting Injectibles.” Phoenix, AZ. August 23, 2013.

532. Orange County Mental Health. “New Treatments in Bipolar Depression.” Anaheim, Ca. September 11, 2013.

533. Hollywood Presbyterian Medical Center. “Physician Burnout.” Hollywood, Ca. September 13, 2013.

534. Chevy Chase Mental Health. “New Treatments in Schizophrenia.” Chevy Chase, Md. September 25, 2013.

535. Northridge Hospital. “Update on DSM V.” Northridge, Ca. September 27, 2013.

536. Riverside County Mental Health. “New Treatments in Bipolar Depression.” Perris, Ca. October 9, 2013.

537. Good Samaritan Hospital. “Evaluation of Suicide Risk.” Los Angeles, Ca. October 16, 2013.

538. Ft. Lauderdale Mental Health. “Misconceptions with Long Acting Injectibles.” Ft. Lauderdale, Fl. October 23, 2013.

539. St. Vincent Hospital. “Physician Burnout.” Los Angeles, Ca. October 24, 2013.

540. UCI Department of Psychiatry. “Bipolar Disorder.” Orange, Ca. November 7, 2013.

541. San Bernardino County Mental Health. “Update on the Use of Clozaril.” Rialto, Ca. November 14, 2013.

542. Van Nuys Medical Center. “Suicide Prevention.” Van Nuys, Ca. November 19, 2013.

543. Garden Grove Medical Center. Drug Abuse and Dependence.” Garden Grove, Ca. November 26, 2013.

544. St. Francis Medical Center. “Latest Treatments in Major Depression.” Lynwood, Ca. January 22, 2014.

545. Riverside County Mental Health. “New Treatments for Bipolar Depression.” Hemet, Ca. March 18, 2014.

546. Glendale Hospital. “Mental Health Evaluation in the Primary Care Setting.” Glendale, Ca. March 26, 2014.

547. Montclair Hospital. Update on Treatment of Depression and Bipolar Disorder.” Montclair, Ca. June 5, 2014.

548. San Diego Private Practice Psychiatrists. “Update on the Use of Long Acting Injectible Antipsychotics.” San Diego, Ca. July 2, 2014.

549. National Association of Physicians of Pakistani Origin. “Maximizing Outcomes in Depression.” Washington DC. August 14, 2014.

550. Northridge Community Medical Center. “Physician Well-Being.” Northridge, California. November 14, 2014.

Rimal B. Bera, MD Page 39

551. St. Jude Medical Center. “Evaluation of Psychiatric Disorders on the Medical Floor.” Fullerton, CA. January 27, 2015.

552. San Antonio Medical Center. “Managing the Disruptive Patient.” Upland, California. February 12, 2015.

553. Fountain Valley Regional Medical Center. “Optimizing Depression Treatment in the Medical Setting.” Fountain Valley, California. March 13, 2015.

554. Los Alamitos Medical Center. Evaluation and Treatment of Co-Morbid Medical and Psychiatric Illness in the Medical Setting.” Los Alamitos, California. April 6, 2015.

555. Lakewood Hospital Medical Center. “The Well-Being of Physicians.” Lakewood, California. July 24, 2015.

556. Anaheim Regional Medical Center. “The Drug Seeking Patient.” Anaheim, California. October 6, 2015.

557. Huntington Beach Hospital. “Effects of Medical Conditions on Mental Health.” Huntington Beach, California. October 15, 2015.

558. Riverside County Mental Health. “Impact of Long Acting Injectables in an Outpatient Mental Health Setting.” Hemet, California. January 19, 2016.

559. Northridge Community Hospital. “Polypharmacy and Delirium.” Northridge, California. February 26, 2016.

560. San Dimas Community Hospital. “Depression in the Primary Care Setting.” San Dimas, California. April 6, 2016.

561. Orlando City Community Physicians. “PseudoBulbar Affect.” Orlando, Florida. April 14, 2016.

562. St. Francis Hospital. “Drug Abuse during Pregnancy.” Lynwood, California. April 27, 2016.

563. Lakewood Medical Center. “Physician Burnout.” Lakewood, California. May 6, 2016.

564. Long Beach Community Mental Health. “A New Treatment for Schizophrenia and Bipolar Disorder.” Long Beach, California. June 20, 2016.

565. Orange County Psychiatrists. “A New Treatment for Schizophrenia and Bipolar Disorder.” Costa Mesa, California. August 22, 2016.

566. Long Beach Community Mental Health. “A New Treatment for Schizophrenia and Bipolar Disorder.” Long Beach, California. June 20, 2016.

567. Kern County-UCLA Medical Center Department of Psychiatry. “The Use of Neuropsychiatric Testing in Schizophrenia.” Bakersfield, California. September 21, 2016.

568. Anaheim Regional Medical Center. “Assessment of Violence.” Anaheim, Ca. January 17, 2017.

Rimal B. Bera, MD Page 40

569. Antelope Valley Medical Center. “Suicide Evaluations.” Victorville, Ca. March 29, 2017.

570. Placentia-Linda Hospital. “PTSD.” Placentia, Ca. May 1, 2017.

571. Palmdale Regional Medical Center. “Suicide Risk Factors.” Palmdale, Ca. May 3, 2017.

572. West Anaheim Medical Center. “Drug-Seeking Patients.” Anaheim, Ca. May 19, 2017.

PERSONAL: Birthdate: August 27, 1961 Birthplace: Hollywood, Ca. Married, Two Children

Rimal B. Bera, MD Page 41